You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • RAS status and neoadjuvant chemotherapy impact CD8+ cells and tumor HLA class I expression in liver metastatic colorectal cancer

Article metrics

Article menu

Download PDFPDF

Research Article
RAS status and neoadjuvant chemotherapy impact CD8+ cells and tumor HLA class I expression in liver metastatic colorectal cancer

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2024

AbstractFullPdf
Dec 2019110
Jan 2020550
Feb 202015155
Mar 2020373713
Apr 202021214
May 2020272713
Jun 202019196
Jul 202018183
Aug 2020272712
Sep 2020545436
Oct 202029295
Nov 202018184
Dec 2020161610
Jan 2021222212
Feb 202114144
Mar 2021212113
Apr 202120207
May 2021171710
Jun 202130307
Jul 202119197
Aug 2021363631
Sep 2021232419
Oct 2021202030
Nov 2021171717
Dec 2021242416
Jan 202221229
Feb 2022212213
Mar 202218188
Apr 202223247
May 2022414131
Jun 2022474829
Jul 202226279
Aug 202234345
Sep 2022323238
Oct 202229309
Nov 2022222422
Dec 202215156
Jan 202319197
Feb 202334349
Mar 202318197
Apr 202310119
May 202315159
Jun 202310103
Jul 202314149
Aug 202320208
Sep 202322226
Oct 202324244
Nov 2023606012
Dec 202312512510
Jan 2024899035
Feb 202431317
Mar 2024202012
Total13901402617